Antoine Papiernik (Sofinnova)
Sofinnova hauls in $548M to build and scale startups — as European VCs step up their biopharma game
When Sofinnova Partners unveiled its $540 million crossover fund earlier this year, the Paris-based power VC player touted its leading role in providing late …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
